Management

Procurement, Preservation and Allocation of Vascularized Organs

---

Patients developing end stage renal disease can be
treated by haemodialysis, peritoneal dialysis or transplantation.
Kidney transplantation is now generally accepted
as the primary therapy for chronic renal failure
in most patients, with the exception of those who
cannot tolerate immunosuppressive treatment or transplant
surgery [1]. Many reasons justify the use of
kidneys from living donors. Although the overall short
and long term results for all donor categories have
increased in recent years, transplants from living
related donors have a higher success rate than those
from cadaver donors [2]. In our experience with living
donor transplantation since 1966, survival of kidney
grafts from living donors is 20% higher at 10 years
than for those from cadaver donors. The introduction
of cyclosporin was responsible for increased survival
of all categories of transplants. In our series this
increase was 15% for cadaveric donors and 20% for
living donors. The benefit was more pronounced in
patients receiving kidneys from parents (+35%) and, in
this category, no effect of age was observed in the long
term analysis.

---

Availability

No copy data

Detail Information

Series Title

-

Call Number

-

Publisher

: ., 1997

Collation

1-372

Language

English

ISBN/ISSN

978-94-010-6280-0

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Procurement, Preservation and Allocation of Vascul

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment